MRNA Jul 2024 145.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:52PM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past year
Key Insights Significantly high institutional ownership implies Moderna's stock price is sensitive to their trading...
- Bloomberg
Moderna's New RSV Vaccine Undercuts the Promise of mRNA
(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and a public health hero. Its second vaccine, meant to prevent a common respiratory virus, is calling into question the premise on which the company has staked its entire business. Most Read from BloombergMicrosoft’s Xbox Is Planning More Cuts After Studio ClosingsAmericans Are Racking Up ‘Phantom Debt’ That Wall Street Can’t Track‘Seriously Underwater’ Home Mortgages Tick Up Across th
- Investor's Business Daily
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Moderna stock broke out of a cup-with-handle base after its first-quarter sales and earnings report. Is MRNA stock a buy right now?
© 2024 Yahoo. All rights reserved.